Sen­ate Re­pub­li­cans seek to re­peal new gov­ern­ment drug price ne­go­ti­a­tions

With the midterm elec­tions ap­proach­ing next month and Re­pub­li­cans like­ly to win back con­trol of ei­ther the House, Sen­ate or both, Re­pub­li­can Sens. James Lank­ford (OK) and Mike Lee (UT) re­cent­ly in­tro­duced a bill that would gut the De­moc­rats’ re­cent drug pric­ing vic­to­ry.

That new law will al­low for drug price ne­go­ti­a­tions, and even po­ten­tial­ly price con­trols (via the threat of steep fines), for a sliv­er of the most ex­pen­sive drugs for se­niors, all of which will have al­ready been on the mar­ket for years.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN